Biocytogen Opens San Francisco Office to Accelerate Globalization
Beijing, China and San Francisco, CA, May 31, 2023 - Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) has announced the opening of a new…
Read more
Biocytogen to Present Pipeline Assets and R&D Progress at BIO International Convention, June 5-8, 2023
Biocytogen’s antibody BD and licensing (BDL) team will be delivering an oral presentation on Monday, June 5th at the 2023 BIO International Convention in Boston,…
Read more
Meet Biocytogen’s APAC Business Development Team at 70th JALAS 2023!
Biocytogen’s Asia-Pacific business development team is pleased to exhibit at the 70th Japanese Association for Laboratory Animal Science (JALAS) annual meeting from May 24-26, 2023…
Read more
Join us at PEGSBoston: May 15-19
Join us in our luncheon presentation and meet with our team at booth #9 in PEGS Boston from May 15-19 ! Learn more about our…
Read more
Join us at ASGCT2023: May 16-20
Join us at booth #574 at American Society of Gene & Cell Therapy Annual Meeting 2023 from May 16-20 in Los Angeles, CA! Learn…
Read more
Meet Biocytogen’s Business Development Team at BIO KOREA 2023!
Biocytogen’s business development team is pleased to exhibit and host 1-on-1 meetings at BIO KOREA 2023, taking place from May 10-12, 2023 in Seoul, South Korea. Join…
Read more
Immune system-reconstituted models for immuno-oncology research: Applications of CD34+ humanized B-NDG mice
Introduction: Choosing the right humanized model for your study The relative success of immuno-oncology drugs has directed research toward discovering novel targets and therapeutic agents.…
Read more
Webinar: Joint, Lung, and Urinary Disease Models Offered at Biocytogen
Our webinar “Joint, Lung, and Urinary Disease Models Offered at Biocytogen" was live at 1:00 PM EDT on May 25th, 2023. About the Webinar Inflammatory disease…
Read more
Join us at Immunology 2023: May 11-15
Join us at booth #4097 at Immunology 2023 from May 11-15 in Washington. D.C! Learn more about our custom model generation services and other platforms…
Read more
Humanized PCSK9 mice as a resource for lipid management studies
Introduction: mitigating dyslipidemia to prevent cardiovascular disease Dyslipidemia is a metabolic derangement that clinically presents with abnormal levels of lipids (cholesterol, triglycerides, and/or phospholipids) in…
Read more